Skip to main content
Fig. 12 | Journal of Neuroinflammation

Fig. 12

From: Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement

Fig. 12

CR2-fH and CR2-Crry treatment but not C3 deficiency improves survival at 7 days post-MCAO. Kaplan-Meier survival analysis of C3-deficient or complement inhibitor-treated mice over a 7-day period post-MCAO. One group of C3-deficient mice received antibiotic prophylaxis (C3 −/− + Anti), n = 19–33, *p < 0.05

Back to article page